The Progress and Promise of Molecular Imaging Probes in Oncologic Drug DevelopmentGary J. Kelloff, Janet Woodcock, Daniel C. Sullivan et al.|Clinical Cancer Research|2005Cited by 220
The FDA and the Next Wave of Drug Abuse — Proactive PharmacovigilanceDouglas C. Throckmorton, Janet Woodcock, Scott Gottlieb|New England Journal of Medicine|2018Cited by 73
Medication development in opioid addiction: Meaningful clinical end pointsNora D. Volkow, Eric Wargo, Sharon Hertz et al.|Science Translational Medicine|2018Cited by 53
Combined Gabapentinoid and Opioid Use: The Consequences of Shifting Prescribing TrendsDouglas C. Throckmorton, Janet Woodcock|Annals of Internal Medicine|2018Cited by 14